Disentangling the effects of tocilizumab on neutrophil survival and function.

about

Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.Effects of tocilizumab on neutrophil function and kinetics.

P2860

Q41585035-8F82A421-40C2-444F-857B-D21EC281AE86 Q48260121-6D729536-03DA-4D9D-A819-0DBF2CA3C51A

P2860

Disentangling the effects of tocilizumab on neutrophil survival and function.

Item

http://www.wikidata.org/entity/Q48044670

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Disentangling the effects of tocilizumab on neutrophil survival and function.

@en

Disentangling the effects of tocilizumab on neutrophil survival and function.

@nl

type

Item

label

Disentangling the effects of tocilizumab on neutrophil survival and function.

@en

Disentangling the effects of tocilizumab on neutrophil survival and function.

@nl

prefLabel

Disentangling the effects of tocilizumab on neutrophil survival and function.

@en

Disentangling the effects of tocilizumab on neutrophil survival and function.

@nl

P1476

Disentangling the effects of tocilizumab on neutrophil survival and function.

@en

P2093

Cindy Strehl

http://www.w3.org/2001/XMLSchema#string

Eugen Feist

http://www.w3.org/2001/XMLSchema#string

Frank Buttgereit

http://www.w3.org/2001/XMLSchema#string

Martin Hahne

http://www.w3.org/2001/XMLSchema#string

Paula Hoff

http://www.w3.org/2001/XMLSchema#string

Timo Gaber

http://www.w3.org/2001/XMLSchema#string

Yvonne Dörffel

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-6: a new therapeutic target

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement

Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment

Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production

Tocilizumab: a review of its use in the management of rheumatoid arthritis

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

Evolving concepts of rheumatoid arthritis

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.

P2888

s12026-015-8770-x

P304

665-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12026-015-8770-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerd-Rüdiger Burmester

P577

2015-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26721805

http://www.w3.org/2001/XMLSchema#string

Disentangling the effects of tocilizumab on neutrophil survival and function.

about

P2860

P2860

Disentangling the effects of tocilizumab on neutrophil survival and function.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698